Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase 2 3Phase 4 2Phase 3 2

Status

Completed 7Unknown 3Recruiting 3Terminated 2Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 2Other neoplasm 1

Conditions

Uterine Neoplasms 1Ovarian Neoplasms 1Malignant Neoplasms of Female Genital Organs 1Leiomyoma 1

Interventions

Cisplatin 62Carboplatin 52Paclitaxel 49Radiotherapy 47Docetaxel 42Gemcitabine 38Cyclophosphamide 36Rituximab 33Capecitabine 28Fluorouracil 27Dexamethasone 27Doxorubicin 26Prednisone 21Bevacizumab 20Pemetrexed 19Oxaliplatin 18Leucovorin 18pembrolizumab 17Vincristine 17Etoposide 17Cytarabine 15Imatinib Mesylate 14Drug Therapy 14Irinotecan 13Filgrastim 13Zoledronic Acid 12Trastuzumab 12Radiosurgery 12Erlotinib Hydrochloride 12Goserelin 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Terminated × Bupivacaine × Clear all
NCT04849858 2024-08-23

Pilot Study of Liposomal Bupivacaine Redosing in Patients Undergoing Major Gynecologic Procedures

University of California, Irvine

Phase 3 Terminated
13 enrolled
Gynecologic

Leiomyoma, Ovarian Neoplasms, Uterine Neoplasms

NCT02740114 2021-10-18

Wound Infiltration With Liposomal Bupivacaine vs. Standard Wound Infiltration With Bupivacaine in Patient's Undergoing Open Gynecologic Surgery on an Enhanced Recovery Pathway

M.D. Anderson Cancer Center

Phase 3 Terminated
105 enrolled 9 charts
GynecologicOther neoplasm

Malignant Neoplasms of Female Genital Organs

Data powered by HemOnc (CC BY 4.0) Colophon âš¡